Clostridium Difficile (C. Difficile) Completed Phase 4 Trials for Bifidobacterium longum (DB19248)

Also known as: C-Difficile / Difficile / C. Difficile

IndicationStatusPhase
DBCOND0120840 (Clostridium Difficile (C. Difficile))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02462590
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization TrialPrevention